In contrast to BRAF driver mutations, KIT driver mutations are present to a higher extent in acral and mucosal melanomas (10.8% and 11.5% respectively) compared to cutaneous melanomas (9.7% in CSD and 5.1% in non-CSD cutaneous melanoma) (96). This evidence concerns the gene BRAF and cutaneous melanoma.